跳至主要内容
临床试验/JPRN-UMIN000036143
JPRN-UMIN000036143已完成未知

Comparisons of changes in circulating vascular endothelial growth factor-A and renal vascular parameters after intravitreal ranibizumab or aflibercept for retinal vascular disease - Comparisons of changes in circulating vascular endothelial growth factor-A and renal vascular parameters after intravitreal ranibizumab or aflibercept for retinal vascular disease

Tosei General Hospital0 个研究点目标入组 40 人开始时间: 2019年3月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who had received systemic anti-VEGF therapy for malignancy. 2)Patients who were currently on dialysis. 3)Patients who had undergone vitrectomy in the treated eye. 4)Patients who had severely high albuminuria (A3 category, KDIGO 2012).

研究者

相似试验